The single research-grade, COA-checked Dihexa source we track: Everything in this and the following two sections is community-reported drawn from forums such as LongeCity, vendor copy, and individual write-ups
Even when injected systemically into abdominal fat, the peptide appears to concentrate at injury sites
Its a well-tolerated, low-risk option that provides fast, noticeable benefits
Severe hepatic or renal impairment high-dose protocols may add metabolic burden
Given the peptide's short plasma half-life (~0.51 hour), daily dosing maintains more consistent exposure to the peptide's gene-expression-modulating effects
If your clinic offers these services, set expectations around the full program (coaching, energy balance, and adherence) rather than the injection alone